Kiaan Pharma Private Limited - Due diligence report

A 360° intelligence report on Kiaan Pharma Private Limited: trust score, financial health, credit view, compliance, directors, growth and di…

2012-08-09 Muzaffarnagar, Uttar Pradesh Active Unlisted Active Compliant
Share
KP Kiaan Pharma Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Kiaan Pharma Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
86/100
Trust Score
Low Risk

Kiaan Pharma Private Limited is assessed as Low Risk with a Trust Score of 86/100. Kiaan Pharma Private Limited is an active private limited indian non-government company incorporated in 2012, operating in the Chemicals and Materials sector. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and moderate financial risk profile.

Report generated on 17 Jul 2026 from the latest processed filings. Kiaan Pharma Private Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
86/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
100/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
70/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
45/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
85/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
60/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
75/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 45/100 Caution Indicated
  • Negative operating earnings - debt service depends on external support.
  • Open charges exceed net worth - secured lenders rank ahead.
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 1 open (40.00 Lakh) · 1 satisfied (65.00 Lakh).

Banking relationships (from registered charges)
LenderChargesAmount
Punjab National Bank1 48.0 cr
Others1 48.0 cr
Compliance Score: 100/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 85/100
NameDIN / PANDesignationAppointedTenureDIN status
Ganga Singh 01234567 Director 01/04/2018 6 yrs Approved
VAISHALI ARPIT RAJVANSHI 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • 1 director exit(s) in the last 3 years.
06

Ownership & Group Intelligence

As per FY 2019 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
1 allotment(s) · 0 transfer(s)

Promoters hold the largest single block of equity - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 60 · Distress 75
Growth signals & trust indicators
Profit expanded 38% year-on-year.
Operating for 13+ years.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
1 open charge(s) registered - assets are encumbered.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence88/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment66/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 1 open charge(s) of 40.00 Lakh already registered.
  • Compliance record supports lending.
Investor view70/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 1 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
29 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
23 Oct 2024
Director appointed
VAISHALI ARPIT RAJVANSHI (Additional Director)
29 Sep 2024
Director ceased
Ganga Singh
05 Feb 2024
Director appointed
Ganga Singh (Director)
23 May 2023
Charge created
Others - 40.00 Lakh
29 Sep 2022
Director ceased
DIVESH KUMAR
22 Dec 2020
Director ceased
AMIT KUMAR KAUSHIK
04 Aug 2019
Director ceased
POONAM GARG
31 Aug 2018
Director ceased
DINESH KUMAR GARG
22 Jul 2017
Director ceased
AGAM RAJVANSHI
Director ceased
ARPIT RAJVANSHI
31 Mar 2015
Director ceased
GYANENDRA VERMA
Director ceased
PAWAN KUMAR VERMA
22 Apr 2014
Charge satisfied
Punjab National Bank
10

Key Observations

Auto-generated from the data above
Debt-to-equity stands at 1.42 - leverage worth monitoring.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
2 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
Promoters hold the largest single block of equity as per the FY 2019 annual return.
Capital has been raised through 1 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Gerald Metals India Private Limited U74140DL2011PTC222490 New Delhi, Delhi, India
Energy Engineers Pvt Ltd U74899DL1980PTC014208 New Delhi, Delhi, India
Himalaya Engineers & Projects Private Limited U31908UP2014PTC229004 Noida, Uttar Pradesh, India
Teenlok Impex Private Limited U51909WB2013PTC198438 Kolkata, West Bengal, India
Shuddh Colon Care U85100TG2014PTC092732 Hyderabad, Telangana, India
Kuloday Securities Private Limited U65993WB1997PTC082815 Kolkata, West Bengal, India
Kite Aero Private Limited U74999GJ2020PTC115635 Bharuch, Gujarat, India
Sigma Polyfilms Pvt Ltd U17119GJ1993PTC020272 Ahmedabad, Gujarat, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Kiaan Pharma Private Limited before audits and certifications: compliance score 100/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Kiaan Pharma Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 45/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 60/100, margin trends, ownership structure and peer set for Kiaan Pharma Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 86/100, distress signals and MSME payment-delay disclosures - know whether Kiaan Pharma Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Kiaan Pharma Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Kiaan Pharma Private Limited an active company?

Kiaan Pharma Private Limited has MCA status “Active” with a compliance score of 100/100 (Low Risk).

Is Kiaan Pharma Private Limited financially healthy?

Kiaan Pharma Private Limited has a Financial Health Score of 70/100 (Moderate) based on its filed financial statements.

Should I do business with Kiaan Pharma Private Limited?

Its overall Trust Score is 86/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Kiaan Pharma Private Limited?

Promoters hold the largest single block of equity - exact percentages are in the full report. 2 active director(s) are on record.

Does Kiaan Pharma Private Limited have loans or charges against its assets?

1 open charge(s) are registered against its assets, and 1 earlier charge(s) stand satisfied.

Is Kiaan Pharma Private Limited up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 100/100 (Low Risk).

Is it risky to lend to Kiaan Pharma Private Limited?

Its Credit Risk Score is 45/100 (Caution Indicated). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.